1. Home /
  2. Drug Approvals

Drug Approvals

We're All Rooting for Gilead Sciences in This Venture

I'm long GILD, but the fact is that the firm is not trying to make money off of Remdesivir at this point.

Can a Covid-19 Vaccine Power Shares of Pfizer Higher?

PFE's charts are constructive and traders could go long at current levels.

Small-Caps Roar, Bets Against the Market, Trading Nvidia

Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.

Indian Generic Maker Glenmark Seeks to Make Japanese Covid-19 Drug

India's drugmakers aim to manufacture generic versions of any coronavirus 'cure', even before the full findings as to how effective they are.

Saving the Service Economy, Gilead Trials and Intel's Earnings: Market Recon

More government funding is approved to fight Covid-19 layoffs, Gilead sells off on early reports around China trials and Intel announces earnings.

Moderna Is Soaring on Funding News so It's Back to the Charts

Let's take a look at the charts and indicators.

AstraZeneca Could Pause a While Before Challenging the Old Highs

Let's review the charts and indicators.

Let's Cut Through All the Noisy Trading in Gilead Sciences

Trading action has been jumpy, so where's the trend?

Biohaven Pharmaceutical Needs More Bottom Development Before Becoming a Buy

You can't rush drugs to market and you can't rush a market bottom.

Jim Cramer: Why a 30-Year Safe and Sound Bond Makes Sense

With a $1 trillion bond, we could be sure that we have national testing and everyone has to be tested, we could actually build the PPE factories and put people to work.